SPC300
Siponimod
Status:
VeittApplication date:
23.6.2020Application published:
15.7.2020Grant published:
15.3.2021
Max expiry date:
20.12.2034Medicine name:
MayzentMedicine for children:
No
Timeline
Today
23.6.2020Application
15.7.2020Publication
15.3.2021Registration
20.12.2034Expires
Marketing license
IS authorization number:
EU/1/19/1414/001-002; EU/1/19/1414/003Date:
21.1.2020
Foreign authorization number:
EU/1/19/1414Date:
13.1.2020
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2379069